Lv5
970 积分 2024-06-05 加入
Novel drug targets in 2025
3天前
已完结
Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial
7天前
已完结
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial
1个月前
已完结
OP0295 A 12-WEEK, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 2B STUDY OF SAFETY, TOLERABILITY AND EFFICACY OF AR882 IN GOUT PATIENTS
1个月前
已完结
Gout
1个月前
已完结
GLP-1R agonists and heart failure: novel beneficial effects suggested by Mendelian randomization
2个月前
已完结
Efficacy and Safety of Oral Icotrokinra in Moderate‐to‐Severe Plaque Psoriasis: A Systematic Review, Meta‐Analysis, and Trial Sequential Analysis
3个月前
已关闭
The Sources, Synthesis, and Applications of Cyclopeptides
3个月前
已完结
Metabolism and Excretion pathways of CD388, a novel drug-Fc conjugate for prevention of seasonal or pandemic influenza
4个月前
已完结
TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198
4个月前
已完结
皖公网安备34019202002308
